These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34607546)

  • 1. Precision Psychiatry: Machine Learning as a Tool to Find New Pharmacological Targets.
    Rema J; Novais F; Telles-Correia D
    Curr Top Med Chem; 2022; 22(15):1261-1269. PubMed ID: 34607546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
    Zhao K; So HC
    IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry.
    Tai AMY; Albuquerque A; Carmona NE; Subramanieapillai M; Cha DS; Sheko M; Lee Y; Mansur R; McIntyre RS
    Artif Intell Med; 2019 Aug; 99():101704. PubMed ID: 31606109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.
    Lin E; Lin CH; Lane HY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning in Neural Networks.
    Lin E; Tsai SJ
    Adv Exp Med Biol; 2019; 1192():127-137. PubMed ID: 31705493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer's disease.
    Tsuji S; Hase T; Yachie-Kinoshita A; Nishino T; Ghosh S; Kikuchi M; Shimokawa K; Aburatani H; Kitano H; Tanaka H
    Alzheimers Res Ther; 2021 May; 13(1):92. PubMed ID: 33941241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep neural networks in psychiatry.
    Durstewitz D; Koppe G; Meyer-Lindenberg A
    Mol Psychiatry; 2019 Nov; 24(11):1583-1598. PubMed ID: 30770893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning techniques in diagnostics and prediction of the clinical features of schizophrenia: a narrative review.
    Gashkarimov VR; Sultanova RI; Efremov IS; Asadullin AR
    Consort Psychiatr; 2023 Sep; 4(3):43-53. PubMed ID: 38249535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning Approaches for Clinical Psychology and Psychiatry.
    Dwyer DB; Falkai P; Koutsouleris N
    Annu Rev Clin Psychol; 2018 May; 14():91-118. PubMed ID: 29401044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data.
    Aliper A; Plis S; Artemov A; Ulloa A; Mamoshina P; Zhavoronkov A
    Mol Pharm; 2016 Jul; 13(7):2524-30. PubMed ID: 27200455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning for Precision Psychiatry: Opportunities and Challenges.
    Bzdok D; Meyer-Lindenberg A
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Mar; 3(3):223-230. PubMed ID: 29486863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning in Neuro-Oncology, Epilepsy, Alzheimer's Disease, and Schizophrenia.
    English M; Kumar C; Ditterline BL; Drazin D; Dietz N
    Acta Neurochir Suppl; 2022; 134():349-361. PubMed ID: 34862559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field.
    Villalobos-Alva J; Ochoa-Toledo L; Villalobos-Alva MJ; Aliseda A; Pérez-Escamirosa F; Altamirano-Bustamante NF; Ochoa-Fernández F; Zamora-Solís R; Villalobos-Alva S; Revilla-Monsalve C; Kemper-Valverde N; Altamirano-Bustamante MM
    Front Bioeng Biotechnol; 2022; 10():788300. PubMed ID: 35875501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning for psychiatric and neurological disorders through a network medicine approach.
    Lüscher Dias T; Schuch V; Beltrão-Braga PCB; Martins-de-Souza D; Brentani HP; Franco GR; Nakaya HI
    Transl Psychiatry; 2020 May; 10(1):141. PubMed ID: 32398742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computing schizophrenia: ethical challenges for machine learning in psychiatry.
    Starke G; De Clercq E; Borgwardt S; Elger BS
    Psychol Med; 2021 Nov; 51(15):2515-2521. PubMed ID: 32536358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new potential candidates to inhibit EGF via machine learning algorithm.
    Torabi M; Yasami-Khiabani S; Sardari S; Golkar M; Pérez-Sánchez H; Ghasemi F
    Eur J Pharmacol; 2024 Jan; 963():176176. PubMed ID: 38000720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.